• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非经典型先天性肾上腺皮质增生症患者对二十四肽促肾上腺皮质激素(赛可同®)试验的皮质醇反应不足:这是规则的例外情况吗?

Inadequate cortisol response to the tetracosactide (Synacthen®) test in non-classic congenital adrenal hyperplasia: an exception to the rule?

作者信息

Stoupa Athanasia, González-Briceño Laura, Pinto Graziella, Samara-Boustani Dinane, Thalassinos Caroline, Flechtner Isabelle, Beltrand Jacques, Bidet Maud, Simon Albane, Piketty Marie, Laborde Kathleen, Morel Yves, Bellanné-Chantelot Christine, Touraine Philippe, Polak Michel

机构信息

Service d'Endocrinologie, Gynécologie et Diabétologie Pédiatriques, Hôpital Universitaire Necker-Enfants Malades, Paris, France.

出版信息

Horm Res Paediatr. 2015;83(4):262-7. doi: 10.1159/000369901. Epub 2015 Feb 7.

DOI:10.1159/000369901
PMID:25677445
Abstract

AIMS

To describe cortisol response to tetracosactide and to review the literature on adrenal function in non-classic congenital adrenal hyperplasia (NCCAH) patients.

METHODS

We compared cortisol responses to tetracosactide (250 μg) between NCCAH patients and a comparison group (CG) of patients with premature pubarche and normal tetracosactide test. An adequate cortisol response was defined as a peak ≥18 μg/dl.

RESULTS

We included 35 NCCAH patients (26 girls, 9 boys), whose mean age at testing was 7.0 years (0.8-15.6), and 47 patients in the CG (39 girls, 8 boys), whose mean age was 7.2 years (0.5-9.9). Baseline cortisol was significantly higher in the NCCAH group than in the CG [12.9 (4.3-22.2) vs. 9.7 (4.2-16.2) μg/dl, respectively; p = 0.0006]. NCCAH patients had lower cortisol peak response compared to the CG [18.2 (6.3-40) vs. 24.9 (12-30.3) μg/dl, respectively; p < 0.0001]. Peak cortisol was <18 μg/dl in 21/35 (60%) NCCAH patients versus 1/47 (2.1%) in the CG. No NCCAH patients had acute adrenal insufficiency, but 2 reported severe fatigue that improved with hydrocortisone.

CONCLUSIONS

The cortisol response to tetracosactide was inadequate (<18 μg/dl) in 60% of patients with NCCAH. Hydrocortisone therapy may deserve consideration when major stress (surgery, trauma, childbirth) or objectively documented fatigue occurs in NCCAH patients with inadequate cortisol response.

摘要

目的

描述皮质醇对二十四肽促肾上腺皮质激素的反应,并综述非经典型先天性肾上腺皮质增生症(NCCAH)患者肾上腺功能的相关文献。

方法

我们比较了NCCAH患者与青春期早熟且二十四肽促肾上腺皮质激素试验正常的对照组(CG)患者对二十四肽促肾上腺皮质激素(250μg)的皮质醇反应。皮质醇反应充分定义为峰值≥18μg/dl。

结果

我们纳入了35例NCCAH患者(26例女孩,9例男孩),检测时的平均年龄为7.0岁(0.8 - 15.6岁),以及47例CG患者(39例女孩,8例男孩),平均年龄为7.2岁(0.5 - 9.9岁)。NCCAH组的基线皮质醇显著高于CG组[分别为12.9(4.3 - 22.2)μg/dl和9.7(4.2 - 16.2)μg/dl;p = 0.0006]。与CG组相比,NCCAH患者的皮质醇峰值反应较低[分别为18.2(6.3 - 40)μg/dl和24.9(12 - 30.3)μg/dl;p < 0.0001]。21/35(60%)的NCCAH患者皮质醇峰值<18μg/dl,而CG组为1/47(2.1%)。没有NCCAH患者出现急性肾上腺功能不全,但有2例报告严重疲劳,氢化可的松治疗后有所改善。

结论

60%的NCCAH患者对二十四肽促肾上腺皮质激素的皮质醇反应不足(<18μg/dl)。当NCCAH患者出现严重应激(手术、创伤、分娩)或客观记录的疲劳且皮质醇反应不足时,可能值得考虑氢化可的松治疗。

相似文献

1
Inadequate cortisol response to the tetracosactide (Synacthen®) test in non-classic congenital adrenal hyperplasia: an exception to the rule?非经典型先天性肾上腺皮质增生症患者对二十四肽促肾上腺皮质激素(赛可同®)试验的皮质醇反应不足:这是规则的例外情况吗?
Horm Res Paediatr. 2015;83(4):262-7. doi: 10.1159/000369901. Epub 2015 Feb 7.
2
Cortisol response to adrenocorticotropin testing in non-classical congenital adrenal hyperplasia (NCCAH).非经典型先天性肾上腺皮质增生症(NCCAH)中皮质醇对促肾上腺皮质激素检测的反应。
J Pediatr Endocrinol Metab. 2016 Dec 1;29(12):1365-1371. doi: 10.1515/jpem-2016-0216.
3
Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche.意大利大样本库中早发性青春期早熟患儿 CYP21A2 基因型与血清 17-羟孕酮和皮质醇水平的关系。
Eur J Endocrinol. 2011 Aug;165(2):307-14. doi: 10.1530/EJE-11-0119. Epub 2011 Jun 6.
4
The Short Cosyntropin Test Revisited: New Normal Reference Range Using LC-MS/MS.短程促肾上腺皮质激素刺激试验再探讨:应用 LC-MS/MS 测定的新的正常参考范围。
J Clin Endocrinol Metab. 2018 Apr 1;103(4):1696-1703. doi: 10.1210/jc.2017-02602.
5
High prevalence of "biochemical" adrenal insufficiency in thalassemics: is it a matter of different testings or decreased cortisol binding globulin?地中海贫血患者中“生化”肾上腺皮质功能不全的高发率:是检测方法不同还是皮质醇结合球蛋白降低所致?
J Clin Endocrinol Metab. 2010 Oct;95(10):4609-15. doi: 10.1210/jc.2010-0205. Epub 2010 Jul 21.
6
Genotype-Specific Cortisol Reserve in a Cohort of Subjects With Nonclassic Congenital Adrenal Hyperplasia (NCCAH).非经典型先天性肾上腺皮质增生症(NCCAH)患者队列中的基因型特异性皮质醇储备
J Clin Endocrinol Metab. 2024 Feb 20;109(3):852-857. doi: 10.1210/clinem/dgad546.
7
Central Precocious Puberty as a Presenting Sign of Nonclassical Congenital Adrenal Hyperplasia: Clinical Characteristics.中枢性性早熟作为非经典型先天性肾上腺皮质增生症的首发表现:临床特征。
J Clin Endocrinol Metab. 2019 Jul 1;104(7):2695-2700. doi: 10.1210/jc.2018-02605.
8
How good is a morning cortisol in predicting an adequate response to intramuscular synacthen stimulation?早上皮质醇水平预测肌肉注射促肾上腺皮质激素刺激反应充分的效果如何?
Clin Endocrinol (Oxf). 2014 Jul;81(1):19-24. doi: 10.1111/cen.12373. Epub 2013 Dec 17.
9
Adrenal status in children with septic shock using low-dose stimulation test.采用低剂量刺激试验评估脓毒性休克患儿的肾上腺状态。
Pediatr Crit Care Med. 2007 Jan;8(1):23-8. doi: 10.1097/01.pcc.0000256622.63135.90.
10
Intramuscular Short-term ACTH Test for the Determination of Adrenal Function in Children: Safe, Effective and Reliable.肌肉内短期 ACTH 试验在儿童肾上腺功能测定中的应用:安全、有效且可靠。
J Clin Res Pediatr Endocrinol. 2020 Sep 2;12(3):241-247. doi: 10.4274/jcrpe.galenos.2019.2019.0099. Epub 2019 Dec 17.

引用本文的文献

1
Diagnostic cut-offs of 17-hydroxyprogesterone by LC-MS/MS in children with non-classical congenital adrenal hyperplasia.采用液相色谱-串联质谱法测定非经典型先天性肾上腺皮质增生症患儿17-羟孕酮的诊断临界值。
J Endocrinol Invest. 2025 Apr 15. doi: 10.1007/s40618-025-02581-w.
2
Treatment and Follow-up of Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency in Childhood and Adolescence.儿童及青少年期21-羟化酶缺乏所致先天性肾上腺皮质增生症的治疗与随访
J Clin Res Pediatr Endocrinol. 2025 Jan 10;17(Suppl 1):12-22. doi: 10.4274/jcrpe.galenos.2024.2024-6-26-S. Epub 2024 Dec 23.
3
Free Cortisol and Free 21-Deoxycortisol in the Clinical Evaluation of Congenital Adrenal Hyperplasia.
游离皮质醇和游离21-脱氧皮质醇在先天性肾上腺皮质增生症临床评估中的应用
J Clin Endocrinol Metab. 2025 Apr 22;110(5):e1334-e1342. doi: 10.1210/clinem/dgae591.
4
Challenges in treatment of patients with non-classic congenital adrenal hyperplasia.非经典型先天性肾上腺皮质增生症患者治疗的挑战。
Front Endocrinol (Lausanne). 2022 Dec 12;13:1064024. doi: 10.3389/fendo.2022.1064024. eCollection 2022.
5
Measuring steroids in hair opens up possibilities to identify congenital adrenal hyperplasia in developing countries.检测毛发中的类固醇可以为发展中国家诊断先天性肾上腺皮质增生症提供可能。
Clin Endocrinol (Oxf). 2023 Jan;98(1):41-48. doi: 10.1111/cen.14754. Epub 2022 May 15.
6
The way toward adulthood for females with nonclassic congenital adrenal hyperplasia.非经典型先天性肾上腺皮质增生女性的成年之路。
Endocrine. 2021 Jul;73(1):16-30. doi: 10.1007/s12020-021-02715-z. Epub 2021 Apr 14.
7
Genotype-phenotype correlations in children and adolescents with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.21-羟化酶缺乏所致非经典型先天性肾上腺皮质增生症儿童及青少年的基因型-表型相关性
Mol Cell Pediatr. 2020 Jul 9;7(1):8. doi: 10.1186/s40348-020-00100-w.
8
Screening for Nonclassic Congenital Adrenal Hyperplasia in the Era of Liquid Chromatography-Tandem Mass Spectrometry.液相色谱-串联质谱时代非经典型先天性肾上腺皮质增生症的筛查
J Endocr Soc. 2019 Dec 18;4(2):bvz030. doi: 10.1210/jendso/bvz030. eCollection 2020 Feb 1.
9
Increased Infection Risk in Addison's Disease and Congenital Adrenal Hyperplasia.Addison 病和先天性肾上腺皮质增生症感染风险增加。
J Clin Endocrinol Metab. 2020 Feb 1;105(2):418-29. doi: 10.1210/clinem/dgz006.
10
Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach.非经典型先天性肾上腺皮质增生症(NCCAH)女性患者的管理:以患者为导向的方法。
Front Endocrinol (Lausanne). 2019 Jun 6;10:366. doi: 10.3389/fendo.2019.00366. eCollection 2019.